Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to David Ross Camidge

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Camidge, David

One or more keywords matched the following items that are connected to Camidge, David

Item Type	Name
Academic Article	New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer.
Academic Article	Cell cycle-associated kinases as targets for therapy in lung cancer.
Academic Article	The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers.
Academic Article	Targeting ALK, ROS1, and BRAF kinases.
Concept	Clinical Trials as Topic
Academic Article	Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group.
Academic Article	Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group.
Academic Article	The impact of socioeconomic status on access to cancer clinical trials.
Academic Article	NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies.
Academic Article	Response assessment criteria for brain metastases: proposal from the RANO group.
Academic Article	A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non-Small Cell Lung Cancer Clinical Trials: A Review of the ClinicalTrials.gov Trial Registry.
Academic Article	Updates in the management of brain metastases.
Academic Article	Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.
Academic Article	First-line Chemotherapy Responsiveness and Patterns of Metastatic Spread Identify Clinical Syndromes Present Within Advanced KRAS Mutant Non-Small-cell Lung Cancer With Different Prognostic Significance.
Academic Article	Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC.
Academic Article	Effectiveness of crizotinib versus entrectinib in ROS1-positive non-small-cell lung cancer using clinical and real-world data.
Academic Article	Extending Our Reach: Expanding Enrollment in Brain Metastases and Primary Brain Tumor Clinical Trials.
Academic Article	Indirect comparisons of brigatinib and alectinib for front-line ALK-positive non-small-cell lung cancer.

Search Criteria

Clinical Trials as Topic